| Financial Year |
March 31 2023 |
| Monetary Funds |
113,954,742.25 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
500,000.00 |
| Accounts Receivable |
211,607,055.02 |
| Advances to Suppliers |
4,430,321.46 |
| Other Receivables |
32,411,339.61 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
87,956,363.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
26,519.25 |
| Other Current Assets |
27,388,639.14 |
| Total Current Assets |
478,274,979.73 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
38,891,579.99 |
| Fixed Assetes |
393,949,542.45 |
| Under-construction Projects |
14,292,126.94 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
79,815,209.76 |
| R&D expenses |
-- |
| Goodwill |
19,624,076.49 |
| Long-Term Deferred and Prepaid Expenses |
56,357,157.44 |
| Deferred Income Tax Assets |
23,720,631.67 |
| Other Non-Current Assets |
17,123,941.12 |
| Sub-Total of Non-Current Assets |
687,819,409.44 |
| Total Assets |
1,166,094,389.17 |
| Short-Term Loans |
45,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
39,156,029.96 |
| Accounts Payable |
120,518,667.36 |
| Accounts Received In Advance |
895,735.13 |
| Employee Compensation Payable |
13,636,358.23 |
| Taxes Payable |
4,326,115.79 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
32,959,864.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
23,462,510.18 |
| Other Current Liabilities |
1,961,606.35 |
| Sub-Total of Current Liabilities |
288,089,882.52 |
| Long-term Loans |
50,107,582.27 |
| Bonds Payable |
152,368,607.35 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
243,224,135.03 |
| Total Liabilities |
531,314,017.55 |
| Paid-In Capital(Or Share Stock) |
201,153,443.00 |
| Capital Surplus |
237,622,581.39 |
| Surplus Reserve |
20,538,626.06 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
116,772,391.01 |
| Minority Stockholder's Interest |
30,148,536.75 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
604,631,834.87 |
| Owner's Equity（Stockholder's Equity） |
634,780,371.62 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,166,094,389.17 |
